- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, January 3, 2025
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An opinion piece in The Sacramento Bee highlighted an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). “Infant Mortality Increases Across US Following Dobbs Decision” reported on the spike in mortality rates in infants living in the US, including a 10% increase in mortality among infants with congenital anomalies.
An article from IT Munch referenced a contributor column published on AJMC.com. In “Want to Provide Better Care? Start With a Better Communications Strategy,” contributor Kathy Ford emphasized the need for communication between doctors and patients to provide the best diagnostic care, as patient history is the most important method of identifying potential diagnoses.
An AJMC.com article, titled “Disparities in Cancer Mortality Among Asian Americans and Pacific Islanders,” was referenced in a piece from The Pinnacle Gazette. The article covered a study that found that cancer mortality rates have decreased by 1.5% in Asian American and Pacific Islander populations between 1999 and 2020.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Radiation Bridging Therapy Boosts CAR T Outcomes in R/R LBCL
April 3rd 2025In this comparative analysis, patients with relapsed/refractory large B-cell lymphoma (R/R LBCL) received bridging therapy via radiation or systemic treatment while their chimeric antigen receptor T-cell therapy (CAR T) was being manufactured.
Read More
